ArticlePLOS digital health2026
Exploratory association between multimodal AI-derived digital biomarkers and in-hospital mortality in adult patients with pneumonia: A proof-of-concept study.
Article in PLOS digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pneumonia remains a leading cause of in-hospital mortality worldwide. Current prognostic tools such as the IDSA/ATS severity score have meaningful limitations, particularly in capturing dynamic disease progression or integrating heterogeneous biological signals. Artificial intelligence (AI) offers the opportunity to derive complementary prognostic information from routinely collected electronic health record data. This exploratory, proof-of-concept retrospective study enrolled adults (≥18 years) admitted with a primary diagnosis of acute pneumonia at Hospital Alma Máter de Antioquia (Medellín, Colombia) between January 1 and June 30, 2024. After applying pre-defined exclusion criteria, 121 patients (19 non-survivors, 15.7%) comprised the final analytic cohort. Three independent AI modules were applied: (i) a ResNet-18 deep learning model quantified lung consolidation from chest radiographs (CXRs) using Class Activation Mapping; (ii) a Spanish regular-expression natural language processing (NLP) pipeline extracted modified IDSA/ATS severity scores from clinical notes; and (iii) NeuroKit2-based quantitative heart rate variability (HRV) analysis processed electrocardiogram (ECG) signals digitised from PDF archives. Bivariate associations with all-cause in-hospital mortality were examined using logistic regression. Several features exhibited statistically significant associations with mortality under conventional thresholds: AI-quantified total lung compromise ratio (OR 8.32, 95% CI 1.23-56.29), NLP-derived IDSA/ATS severity score (OR 1.78, 95% CI 1.09-2.88), and a coherent ECG/HRV profile characterised by higher heart rate (120.1 vs. 84.4 bpm, p = 0.023), reduced RMSSD (4.1 vs. 23.5 ms, p = 0.041), reduced Poincaré SD1 (3.0 vs. 17.6 ms, p = 0.041), and T-wave amplitude reductions surviving FDR correction in multiple leads. Given the small sample size and low event count (n = 19; events-per-variable ≈ 4), all associations are preliminary and hypothesis-generating only. These proof-of-concept findings suggest that integrated multimodal AI biomarkers automatically derived from low-resource clinical data can capture a cardiopulmonary stress profile associated with pneumonia mortality, and support the design of larger prospective validation studies.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.